Video Shorts

2:07
Navigating Long-Term Care Following CAR T-Cell Therapy in Myeloma
6 months ago
by
Jesús Berdeja, MD

1:47
How Community Helps Oncology Professionals Achieve Work-Life Harmony
6 months ago
by
Timothy I. Shaw, PhD

0:53
Darlifarnib in Clear Cell Renal Cell Carcinoma
6 months ago
by
Adanma Ayanambakkam, MD, MS

1:20
Why Palliative Care Needs to Start Earlier for AYA Patients With Sarcoma
6 months ago
by
Vinayak Venkataraman, MD

2:09
Treatment Considerations Following Covalent BTK Inhibitors in CLL
6 months ago
by
Alexey V. Danilov, MD, PhD

1:22
Highlighting the NCCN Advocacy Academy Program
6 months ago
by
Alyssa Schatz, DrPH, MSW

2:35
Selecting Second-Line Therapy in R/R Myeloma
6 months ago
by
Noopur S. Raje, MD

0:55
Staging Pitfalls in Esophageal Cancer Could Alter Curative Intent Decisions
6 months ago
by
Peter C. Enzinger, MD, Dana-Farber Cancer Institute

0:42
The Potential Role of Tumor-Informed ctDNA Testing in Early TNBC
6 months ago
by
Marija Balic, MD, PhD

1:20
Should We Prescribe Exercise Like We Prescribe Chemotherapy in Sarcoma?
6 months ago
by
Vinayak Venkataraman, MD

4:12
OncLive News Roundup for the Week of 4/12
7 months ago
by
Chris Ryan(+1 more)

0:45
How Should Bone Pain Be Interpreted in Patients With Cancer on Bone-Modifying Agents?
7 months ago
by
R. Lor Randall, MD, FACS

1:02
Raising Awareness for PD-L1 Testing for Head and Neck Cancer
7 months ago
by
Fangdi Sun, MD

0:36
Safely Incorporating Integrative Medicine Into Breast Oncology
7 months ago
by
Lillian Rodich, MSPAS, MPH

0:24
Examining the Potential Role of ctDNA-Guided Therapy in RCC
7 months ago
by
Taigo Kato, MD, PhD

0:44
Highlighting the Importance of PD-L1 Testing for Head and Neck Cancer
7 months ago
by
Ranee Mehra, MD

1:13
Spotlighting the Future of Triple-Negative Breast Cancer Management
7 months ago
by
Rena D. Callahan, MD

0:41
Targeting CALR Mutations in Myeloproliferative Neoplasms
7 months ago

2:51
Recapping the Most Important Data and Developments From SGO 2026!
7 months ago
by
Caroline Seymour(+2 more)

0:40
Evaluating the Landscape of Radioligand Therapies in Prostate Cancer
7 months ago
by
Jeff Michalski, MD, MBA, FASTRO

1:13
Significance of the KEYNOTE-B96 Results in Recurrent PROC
7 months ago
by
Bradley Monk, MD, FACOG, FACS

0:35
Final OS Data From the ROSELLA Trial in PROC
7 months ago
by
Alexander B. Olawaiye, MD

0:39
Gathering Expert Insights at SGO 2026!
7 months ago
by
Caroline Seymour(+1 more)

0:28
Data From the CARE Trial in Recurrent/Advanced Endometrial Cancer
7 months ago
by
Yang Sun, MD

0:26
Efficacy of Pamirtecan in HER2-Expressing Endometrial Cancer
7 months ago
by
Bhavana Pothuri, MD

0:27
Using Social Media to Build a Presence in Gynecologic Oncology
7 months ago
by
Megan Hutchcraft, MD

0:27
Testing the Bispecific Antibody REGN5668 in Gynecologic Cancers
7 months ago
by
Roisin E. O'Cearbhaill, MD

4:19
OncLive News Roundup for the Week of 4/5
7 months ago
by
Chris Ryan(+1 more)

0:38
Preparing for SGO 2026 in Puerto Rico!
7 months ago
by
Caroline Seymour(+1 more)

0:39
Initiating Productive Conversations About Weight Gain During Breast Cancer Treatment
7 months ago
by
Patricia Jakel, MSN
Advertisement
Advertisement
Trending on OncLive
1
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ESMO 2026
2
TP53 Comutations, Long-Term Toxicity, and Sunvozertinib Access Shape EGFR+ NSCLC Treatment Decisions
3
Phase 1 Study of BGB-B2033 (GPC3 x 4-1BB Bispecific Antibody) Monotherapy: First Disclosure of Dose Optimization and Dose Escalation Update in Advanced Hepatocellular Carcinoma
4
Outpatient Models and Prophylactic Measures Help Bring Bispecifics Into Community Practice for R/R Myeloma
5
